Law360
FDA Focus: What Sidley Austin's Practice Chair Is Watching
February 22, 2019
Becky Wood, co-chair of the Food Drug and Medical Device Regulatory practice at Sidley and former chief counsel of the FDA, tells Law360 she's tracking U.S. Supreme Court action on drug and device safety, eyeing new approaches to product approvals and fretting about political impacts on FDA recruiting.
A D.C.-based partner, Becky has been at Sidley for most of a two-decade career devoted to drug and device law. She stepped away in 2017 and 2018 for a high-profile stint as the FDA's top lawyer.
This interview has been edited for length and clarity.
Offices
Capabilities
Suggested News & Insights
Digital Health Transformation: A Practical Guide for Life Sciences CompaniesJanuary 18, 20232023 — The Year “Modernization” Comes to the U.S. Cosmetics IndustryJanuary 5, 2023U.S. Oversight Agencies Identify Program Integrity Risks Related to Increased Telehealth Usage During the PandemicDecember 13, 2022Switzerland Will Open Its Market for U.S. Food & Drug Administration (FDA) - Regulated Medical DevicesDecember 7, 2022One Step Forward, Two Steps Back: FDA’s Final Guidance on Clinical Decision Software Raises More Questions Than AnswersOctober 26, 2022New Swiss Data Protection Act – And a New Swiss-U.S. Trans-Atlantic Data Privacy Framework?October 25, 2022
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
